G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,642 | -23,952 | -85,288 | -61,197 | -41,279 |
| Depreciation Amortization | 129 | 64 | 175 | 115 | 67 |
| Other Working Capital | 2,534 | -1,462 | 573 | 1,025 | 1,241 |
| Other Operating Activity | 7,545 | 3,804 | 10,233 | 6,978 | 3,702 |
| Operating Cash Flow | $-44,434 | $-21,546 | $-74,307 | $-53,079 | $-36,269 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -392 | -216 | -709 | -598 | -184 |
| Investing Cash Flow | $-392 | $-216 | $-709 | $-598 | $-184 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 947 | 269 | 341,386 | 341,003 | 121,391 |
| Common Stock Repurchased | N/A | N/A | -892 | -614 | -523 |
| Financing Cash Flow | $947 | $269 | $340,494 | $340,389 | $120,868 |
| Beginning Cash Position | 369,290 | 369,290 | 103,812 | 103,812 | 103,812 |
| End Cash Position | 325,411 | 347,797 | 369,290 | 390,524 | 188,227 |
| Net Cash Flow | $-43,879 | $-21,493 | $265,478 | $286,712 | $84,415 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,434 | -21,546 | -74,307 | -53,079 | -36,269 |
| Capital Expenditure | -392 | -216 | -709 | -598 | -184 |
| Free Cash Flow | -44,826 | -21,762 | -75,016 | -53,677 | -36,453 |